Gara Jalqabaatti › Crisis Vaso-Occlusive
Qorannoo klinikaalii Crisis Vaso-Occlusive Ameerikaa Keessatti hirmaatuu
Qorannoo 7 Crisis Vaso-Occlusive f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
Naannoon
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 hanga 100 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06439082Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 5 hanga 20 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07369024Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT06699849Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT07224360Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
Namoota walitti qabaa jiraSadarkaa 4
6 Months – 100 Years · Saalaa hunda · Haaromfame 08-Wax-2026 · NCT04657822Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Namoota walitti qabaa jira
Umuriin 6 hanga 25 · Saalaa hunda · Haaromfame 18-Cam-2026 · NCT03353584Sickle Cell Improvement: Enhancing Care in the Emergency Department
Namoota walitti qabaa jira
Hanga umuriin 18 · Saalaa hunda · Haaromfame 14-Hag-2023 · NCT05373771Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.